FDA Clears New Type of Knee Implant | Arthritis Foundation
WEBApr 25, 2023 · The U.S. Food and Drug Administration (FDA) recently approved the first implantable shock absorber for people with early-stage knee osteoarthritis (OA). The device, called the MISHA Knee System, is intended for patients who have pain despite receiving nonsurgical treatments such as weight loss …
Mayo Clinic offers unique regenerative medicine procedure for knee …
WEBAug 29, 2023 · RECLAIM is a one-stage innovative procedure for hip and knee that enables tissue growth and restoration of cartilage in the patient's joint. Within one year, the defect is filled. DNA analysis has shown this to be patient …
Osteoarthritis Breakthrough: New Research Shows That the
WEBNov 11, 2023 · A groundbreaking study from the University of Adelaide reveals that osteoarthritis may be reversible through a new treatment targeting Gremlin 1 gene-marked stem cells.
New study shows durability of minimally invasive procedure to …
WEB14 hours ago · "Knee osteoarthritis is a leading cause of adult disability and, until now, most minimally invasive treatment options have been proven to provide only short-term relief, measured in weeks or ...
OHSU clinical trial validates new, FDA-cleared technique for knee ...
WEBApr 12, 2023 · The Food and Drug Administration on Monday granted authorization to market a new implantable shock absorber to treat mild to moderate cases of osteoarthritis causing arthritic pain and loss of function in patients. Federal clearance of the MISHA knee system clears the way for widespread adoption of the first new surgical treatment for ...
New Treatment Target Discovered That Halts Osteoarthritis-Like Knee ...
WEBJan 14, 2021 · In a new series of tests they created nanotherapeutics by attaching a potent EGFR ligand, transforming growth factor-alpha, onto synthetic nanoparticles, to inject into mice who already had cartilage damage in their knees.
Emerging and New Treatment Options for Knee Osteoarthritis
WEBIn this narrative review, we focus on emerging OA knee treatments, relieving symptoms, and regenerating damaged articular cartilage that includes intra-articular human serum albumin, conventional disease-modifying anti-rheumatic drugs (DMARDs), metformin, lipid-lowering agents (statin), nerve growth factors antagonists, bone morphogenetic ...
Promising novel treatment for osteoarthritis revealed by new …
WEBJun 5, 2023 · A newly published study in the journal Osteoarthritis and Cartilage explores the role of the human TSG-6 protein in osteoarthritis (OA), and evaluated the disease modifying potential of...
Osteoarthritis of the Knee | New England Journal of Medicine
WEBJan 6, 2021 · Topical nonsteroidal antiinflammatory drugs (NSAIDs) are a first-line treatment for knee osteoarthritis, given evidence of benefit similar to that with oral NSAIDs but with fewer adverse...
Knee osteoarthritis: disease burden, available treatments, and …
WEBSep 15, 2024 · Osteoarthritis (OA) is a degenerative disorder of synovial joints characterized by progressive articular cartilage damage; structural alterations of subchondral bone, menisci, ligaments, joint capsule, and periarticular muscles; and degrees of synovial proliferation, resulting in substantial joint pain, stiffness, and functional limitations. 1–3 Clinical presentation of knee OA (OAK) and ...